BeautyHealth Announces Scheduled Release of Q4 and Full-Year 2023 Financial Results on March 12, 2024

The Beauty Health Company (NASDAQ: SKIN), renowned for its flagship brand Hydrafacial™, has revised its announcement regarding the reporting of fourth-quarter and full-year 2023 financial results. The company now plans to disclose these results on Tuesday, March 12, 2024, deviating from the initial schedule of February 29, 2024.

To unveil the financial outcomes, a dedicated investor conference call and webcast are scheduled for 4:30 p.m. ET on March 12, with a preceding press release offering comprehensive details. Interested parties can access the live webcast on the Company’s investor relations website at , where supporting materials will also be available. A recording of the call will be posted on the site approximately three hours after its conclusion.

Attributing the delay to unforeseen challenges, the company cites its inability, without undue effort or expense, to submit the Annual Report on Form 10-K for the year ending December 31, 2023, by the original deadline of February 29, 2024. The Beauty Health Company will file Form 12b-25 with the U.S. Securities and Exchange Commission on February 29, 2024, thereby securing a fifteen-day extension to finalize and submit the Annual Report.

For transparency and compliance purposes, the company disseminates important information through various channels, including SEC filings, press releases, public conference calls, and its investor relations website . This ensures the proper disclosure of material non-public information and adherence to disclosure obligations under Regulation FD.

Source Link